🔗 Share this article

An underground market for unlicensed slimming drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, according to new investigations.

Experimental Treatment Gaining Popularity Online

Retatrutide, which remains in research studies, is being promoted by social media influencers for its supposed fat-burning effects. Followers are urged to message these profiles privately for source information, while also receiving discount codes.

Thriving Commerce on Messaging Platforms

Additionally, a robust trade exists on messaging services, where groups with numerous of members share “before and after” photos, injection guides and claims of rapid British shipping. Sellers market the drug there before redirecting buyers to other platforms for transactions.

Learning About Retatrutide

Retatrutide is an investigational injectable created by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – GLP-1, GIP and glucagon. Early trials suggest it could assist patients reduce up to 25% of their total weight. Nicknamed the “triple G”, the substance is being promoted digitally as the next Ozempic.

Medical Professionals Voice Worries

Nevertheless, doctors and pharmacists have cautions that the distribution of what is still an unapproved drug in the United Kingdom is a cause for concern and could lead to individuals administering substances of uncertain source.

Several experts stated the popularity for retatrutide could be connected to the increasing cost of licensed weight loss treatments such as Mounjaro.

Regulatory Position and Implementation

Selling retatrutide on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unlicensed medication that cannot be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Some content creators try to sidestep the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and supply can still violate medicines, marketing, and customer laws, potentially leading to fines, legal action or imprisonment.

Service Reaction and Material Elimination

Based on TikTok, the service has taken down violative material and prohibited related keywords and query recommendations. The company said it was dedicated to maintaining the service safe and investing in enhancing compliance measures.

Digital Trading Activities

Research also found groups with up to 9,000 members marketing the experimental drug using the platform's integrated discovery tool, which functions like a public directory. Typing “retatrutide” immediately displays groups with thousands of members, populated with photos of weight loss, positive reviews and detailed guides for preparing or administering at home.

After minutes of joining one group, a seller shared WhatsApp details, where most transactions take place. The seller sent an guidebook and guaranteed delivery within 48 hours. When asked whether the product was authentic, one seller said: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. None inquired about weight, medical conditions or past usage.

Item Information and Costs

Within these groups, messages show black plastic packages with Royal Mail labels, stating to include new batches. One message read: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, prepared at home with purified liquid, or ready-to-use pens usually sold at £160 for 20 milligrams. When questioned how long a injector should be used, sellers give contradictory answers ranging from a several days to “depends on your body”.

Platform Oversight and Safety Actions

A representative for the messaging service said it regularly monitored harmful content on its platform including content that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Cautions

“Individuals are administering substances they can’t verify. Even if the research behind this drug is sound, these digital products may not contain what they claim,” said a pharmacy expert, the head of pharmacy at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor connected the increase in interest to recent price rises for approved weight-loss medications such as Mounjaro. “With costs rising, individuals are turning to social media. But fake treatments are highly risky. You can’t be certain what’s inside or whether the conditions they were made in was sterile,” she explained.

Her staff has already seen individuals harmed by personal administration from unverified suppliers. “We understand the frustration, but purchasing from messaging apps or communication platforms is gambling with your health,” stated Wyllie. “These materials could be contaminated or improperly measured.”

Manufacturer Statement

A representative from the pharmaceutical company stated the substance was in phase 3 research studies and had not been evaluated or approved by any government authority globally. “Consequently at this time no one can market [it] for human use,” they said, noting that any product “misleadingly claiming itself as a Lilly investigational product not yet approved … may expose users to potentially significant medical dangers”.